Changes between two versions
What changed between the plenary report and the adopted text
From · plenary report· 14 Nov 2025
on ensuring the faster registration and uptake of biological control agents
To · adopted text· 25 Nov 2025
Ensuring faster registration and uptake of biological control agents
AI:What changed, in short
The versions differ only in formal points: punctuation and number formatting are corrected.12
0 changes of substance · 2 formal · 0 of wording only
Written by AI from the two texts only · read the changes before relying on it · 4 Sept 2026 · Report a problem
Changes to the text itself, in document order. Cover page, citations and punctuation-only edits are left out; they are under “Every difference”.
Changes of substance · 0
None: the changes are formal or of wording only.
2 formal changes: legal basis, citations, references, corrections
Change 1 Formal
AI summary:Fixes punctuation: replaces a hyphen with a period after the initial 'I'.
Show the text change (1 line)
Changed:II. whereas the fast-track processing and placing on the EU market of biological control would increase availability and provide an opportunity to combat the resistance of pests and diseases to current PPPs; whereas this would help to promote more sustainable agricultural practices and increase the resilience and competitiveness of the agricultural sector by keeping the farmers’ toolbox of pest control options as broad as possible;
Change 2 Formal
AI summary:Changes the decimal separator in the amount from a period to a comma, aligning with European formatting.
Show the text change (1 line)
Changed:M. whereas EU-based small and medium-sized biocontrol enterprises represent approximately 70 % of the EU biocontrol sector; whereas these companies are key drivers of sustainable innovation; whereas the approval of active substances for PPPs, including biological control agents in the EU, entails significant costs, with overall investment, including data generation, regulatory fees and national authorisations, estimated at between EUR 1.51,5 and EUR 4 million per substance;